You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
東陽光藥(01558.HK)與阿里健康(中國)訂立戰略合作框架協議
格隆匯 12-11 20:23

格隆匯12月11日丨東陽光藥(01558.HK)發佈公告,於2019年12月11日,公司與阿里健康科技(中國)有限公司訂立了一份戰略合作框架協議,據此,公司將與阿里健康(中國)開展流行性感冒專項項目合作,包括:利用阿里健康(中國)碼上放心平台的藥品追溯體系,協助公司進行供應鏈管理優化,通過掃碼增強患者教育服務;藉助阿里健康生態,面向公眾普及流感防治相關知識,並探索東陽光品牌在互聯網用户的認知建設。合作期限為一年。該戰略合作框架協議乃響應中國國務院發佈的關於實施健康中國行動的意見,堅持預防為主,倡導健康文明生活方式,預防控制重大疾病。

據悉,阿里健康(中國)是一家在中國境內開展藥品電商、醫療大數據及人工智能、互聯網醫療服務、消費醫療平台及健康管理等業務的公司,併為於香港聯交所上市的阿里健康信息技術有限公司(00241.HK)的間接全資子公司。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account